儿童鼻内咪达唑仑最佳给药容积:一项随机临床试验
本研究为随机、单盲、三臂、优效性临床试验,纳入1–7岁需行裂伤修复并接受0.5 mg/kg鼻内咪达唑仑(5 mg/mL)的儿童,随机分为0.2、0.5、1 mL三种给药容积组。主要终点为达到最小镇静(University of Michigan镇静量表评分1分)的时间,三组分别为4.7分钟(95%CI 3.8–5.4)、4.3分钟(95%CI 3.9–4.9)、5.2分钟(95%CI 4.6–7.0)。除临床医生对给药便利性满意度在0.2 mL组较低外,次要结局无差异。作者认为三种容积临床结局相当,0.5 mL相比1 mL达到最小镇静时间略短。
要点
- 1–7岁儿童裂伤修复使用0.5 mg/kg鼻内咪达唑仑(5 mg/mL)时,0.2、0.5、1 mL三种给药容积达到最小镇静的时间分别为4.7、4.3、5.2分钟,临床结局相当。
- 0.5 mL容积相比1 mL达到最小镇静时间略短(4.3分钟 vs 5.2分钟),但所有三种容积临床结局可比。
- 0.2 mL给药容积时,对给药便利性满意的临床医生较少。
- 研究纳入99例儿童,96例纳入主要终点分析,程序性痛苦结局仅分析90例。
适用人群与场景
- 1至7岁、需行裂伤修复并接受0.5 mg/kg鼻内咪达唑仑(5 mg/mL)的儿童。
诊断标准与关键阈值
- 最小镇静定义为University of Michigan镇静量表评分为1分。
处置流程与药物剂量
- 鼻内给予咪达唑仑0.5 mg/kg(浓度5 mg/mL),给药容积随机分为0.2、0.5或1 mL。
研究设计与关键结果
- 随机、单盲、三臂、优效性临床试验,纳入99例儿童,96例纳入主要终点分析,程序性痛苦结局分析90例。
- 达到最小镇静时间:0.2 mL组4.7分钟(95%CI 3.8–5.4),0.5 mL组4.3分钟(95%CI 3.9–4.9),1 mL组5.2分钟(95%CI 4.6–7.0)。
- 除临床医生对给药便利性满意度在0.2 mL组较低外,其余次要结局(程序性痛苦、操作开始时间、最深镇静水平、不良事件、临床医生和照护者满意度)无差异。
证据类型、等级与局限
- 证据类型:随机、单盲、三臂、优效性临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为三种给药容积产生相当的临床结局,0.5 mL相比1 mL达到最小镇静时间略短;0.2 mL时临床医生对给药便利性满意度较低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: The optimal intranasal volume of administration for achieving timely and effective sedation in children is unclear. We aimed to compare clinical outcomes relevant to procedural sedation associated with using escalating volumes of administration to administer intranasal midazolam.
METHODS: We conducted a randomized, single-blinded, 3-arm, superiority clinical trial. Children aged 1 to 7 years and undergoing laceration repair requiring 0.5 mg/kg intranasal midazolam (5 mg/mL) were block-randomized to receive midazolam using 1 of 3 volumes of administration: 0.2, 0.5, or 1 mL. Procedures were videotaped, with outcome assessors blinded to volume of administration. Primary outcome was time to onset of minimal sedation (ie, score of 1 on the University of Michigan Sedation Scale). Secondary outcomes included procedural distress, time to procedure start, deepest level of sedation achieved, adverse events, and clinician and caregiver satisfaction.
RESULTS: Ninety-nine children were enrolled; 96 were analyzed for the primary outcome and secondary outcomes, except for the outcome of procedural distress, for which only 90 were analyzed. Time to onset of minimal sedation for each escalating volume of administration was 4.7 minutes (95% confidence interval [CI] 3.8 to 5.4 minutes), 4.3 minutes (95% CI 3.9 to 4.9 minutes), and 5.2 minutes (95% CI 4.6 to 7.0 minutes), respectively. There were no differences in secondary outcomes except for clinician satisfaction with ease of administration: fewer clinicians were satisfied when using a volume of administration of 0.2 mL.
CONCLUSION: There was a slightly shorter time to onset of minimal sedation when a volume of administration of 0.5 mL was used compared with 1 mL, but all 3 volumes of administration produced comparable clinical outcomes. Fewer clinicians were satisfied with ease of administration with a volume of administration of 0.2 mL.
参考来源
- Tsze DS, Ieni M, Fenster DB, et al. Optimal Volume of Administration of Intranasal Midazolam in Children: A Randomized Clinical Trial. Ann Emerg Med. 2016. PMID: 27823876. doi:10.1016/j.annemergmed.2016.08.450
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。